A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cinolazepam
Allicin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Allicin.
Cinolazepam
Dutogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Dutogliptin.
Cinolazepam
Ipragliflozin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Ipragliflozin.
Cinolazepam
Insulin tregopil
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin tregopil.
Cinolazepam
Insulin peglispro
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin peglispro.
Cinolazepam
Insulin degludec
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin degludec.
Cinolazepam
Insulin beef
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin beef.
Cinolazepam
Lixisenatide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Lixisenatide.
Cinolazepam
Ciglitazone
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Ciglitazone.
Cinolazepam
Rivoglitazone
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Rivoglitazone.
Cinolazepam
Netoglitazone
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Netoglitazone.
Cinolazepam
Dulaglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Dulaglutide.
Cinolazepam
Albiglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Albiglutide.
Cinolazepam
Benfluorex
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Benfluorex.
Cinolazepam
Glibornuride
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glibornuride.
Cinolazepam
Gosogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gosogliptin.
Cinolazepam
Liraglutide
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Liraglutide.
Cinolazepam
Alogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Alogliptin.
Cinolazepam
Bisegliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Bisegliptin.
Cinolazepam
AMG-222
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with AMG-222.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3